To address safety concerns related to data collection activities, the HOS survey administration period scheduled to begin April 2020 has been postponed until late summer.
- If the COVID-19 PHE continues through this time and CMS decides not to proceed with this activity, information from the 2019 data collection period will be used to determine 2022 Star Ratings. Survey data from 2019 will be used to determine 2021 Star Ratings for HOS measures.
CMS expects health plans, like Humana, to continue to gather data during 2020 for submission in 2021. This data will be used to determine Star Ratings for plan year 2022. With this in mind, there are no other changes identified at this time for MY2020 data collection activities related to measures assessed via HEDIS, CAHPS, prescription drug events or administrative data exchanges with CMS or their independent review entities.
In March, we began assessing the outreach campaigns and other efforts designed to impact your Humana-covered patients’ health outcomes, as well overall quality performance. We have paused campaigns with calls to action that could have resulted in individuals leaving their home and/or creating noncritical demand on the healthcare system. We will continue to monitor and reassess these activities, along with many other factors, including the impact of COVID-19 in the communities we serve.